FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Triamcinolone 0.1% oromucosal paste (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adcortyl in Orabase 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mefoxin 1g powder for solution for injection vials (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 2g powder for solution for injection vials (Imported (Canada)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amoxapine 100mg tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 1g powder for solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mefoxin 2g powder for solution for injection vials (Organon Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone 0.1% oromucosal paste 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 1g powder for solution for injection vials 5 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amoxapine 100mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Defanyl 100mg tablets (Imported (France)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone 0.1% oromucosal paste 10 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 1g powder for solution for injection vials (Imported (Canada)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adcortyl in Orabase 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) 10 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Asendis 100mg tablets (Goldshield Healthcare Ltd) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 1g powder for solution for injection vials (Imported (Canada)) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Defanyl 100mg tablets (Imported (France)) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mefoxin 1g powder for solution for injection vials (Organon Pharma (UK) Ltd) 5 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone 0.1% oromucosal paste (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mefoxin 2g powder for solution for injection vials (Organon Pharma (UK) Ltd) 5 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Adcortyl In Orabase for Mouth Ulcer 0.1% oromucosal paste (Bristol-Myers Squibb Pharmaceuticals Limited) 5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 2g powder for solution for injection vials (Imported (Canada)) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Alliance Healthcare (Distribution) Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Alliance Healthcare (Distribution) Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clobetasol 500microgram / Neomycin 5mg / Nystatin 100,000units/g cream (Ennogen Healthcare Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely amphotericin B 10 milligram/1 each conventional release oromucosal lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ubidecarenone 200mg capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ubidecarenone 200mg capsules 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bio-Quinone Q10 MEGA 200mg capsules (Pharma Nord (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amphotericin 10mg lozenges 60 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amphotericin B 10mg lozenges sugar free (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fungilin 10mg lozenges (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lamberts Co-Enzyme Q10 200mg capsules (Lamberts Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amphotericin B 10mg lozenges sugar free 1 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fungilin 10mg lozenges (Bristol-Myers Squibb Pharmaceuticals Limited) 60 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lamberts Co-Enzyme Q10 200mg capsules (Lamberts Healthcare Ltd) 60 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bio-Quinone Q10 MEGA 200mg capsules (Pharma Nord (UK) Ltd) 60 capsule 2 x 30 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Amphotericin B 10mg lozenges sugar free (Special Order) 1 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (Niche Pharma Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Niche Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (Niche Pharma Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Promazine 50mg tablets (Niche Pharma Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ferric derisomaltose 100mg/2ml solution for injection ampoules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ferric derisomaltose 100mg/2ml solution for injection ampoules 25 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diafer 100mg/2ml solution for injection ampoules (Pharmacosmos UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diafer 100mg/2ml solution for injection ampoules (Pharmacosmos UK Ltd) 25 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (Actavis UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (Special Order) 1 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (A A H Pharmaceuticals Ltd) 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (Martindale Pharmaceuticals Ltd) 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bismuth subgallate 300mg suppositories (Actavis UK Ltd) 12 suppository VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Arginine 500mg capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely haloperidol 500 microgram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Sandoz Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Crescent Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (A A H Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Sandoz Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Unichem Plc) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Kent Pharma (UK) Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Haloperidol 500microgram tablets (Crescent Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
kliniderm Foam Silicone Border dressing 15cm x 20cm (Aria Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
kliniderm Foam Silicone Border dressing 15cm x 20cm (Aria Medical Ltd) 1 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
kliniderm Foam Silicone Border dressing 15cm x 20cm (Aria Medical Ltd) 5 dressing VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely ketoconazole 200 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nizoral 200mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets (HRA Pharma UK & Ireland Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets (HRA Pharma UK & Ireland Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nizoral 200mg tablets (Janssen-Cilag Ltd) 30 tablet 3 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Thame Laboratories Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ketoconazole 200mg tablets (A A H Pharmaceuticals Ltd) 60 tablet 6 x 10 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Thame Laboratories Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Thame Laboratories Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Thame Laboratories Ltd) 300 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Microdot Universal lancets 1.8mm/26gauge (Cambridge Sensors Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Children's Cough & Sore Throat syrup (McNeil Products Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lancets sterile single use 1.8mm/26gauge 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Microdot Universal lancets 1.8mm/26gauge (Cambridge Sensors Ltd) 200 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Benylin Children's Cough & Sore Throat syrup (McNeil Products Ltd) 125 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely furosemide 1 milligram/1 milliliter conventional release oral solution VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely auranofin 3 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Furosemide 5mg/5ml oral solution sugar free 1 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Auranofin 3mg tablets (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 63 of 86 Next End

This concept is not in any reference sets

Back to Start